Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 9-MTH group results

Feb 1 (Reuters)-  
             Taisho Pharmaceutical Holdings Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              215.80              216.43           279.50     
                   (-0.3 pct)          (-3.8 pct)       (-0.1 pct)   
  Operating           28.56               26.56            33.50     
                   (+7.5 pct)          (+16.9 pct)      (+4.8 pct)   
  Recurring           33.38               31.38            38.50     
                   (+6.4 pct)          (+7.8 pct)       (+1.2 pct)   
  Net                 26.46               23.67            30.00     
                   (+11.8 pct)         (+26.5 pct)      (+4.2 pct)   
  EPS              331.19 yen          296.21 yen       375.47 yen   
  EPS Diluted      330.92 yen          296.01 yen                    
  Ann Div                              110.00 yen       110.00 yen   
  -Q2 div           50.00 yen           50.00 yen                    
  -Q4 div                               60.00 yen        60.00 yen   
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news